Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

作者: Timothy J. Craig , Robyn J. Levy , Richard L. Wasserman , Againdra K. Bewtra , David Hurewitz

DOI: 10.1016/J.JACI.2009.07.017

关键词:

摘要: Background Hereditary angioedema caused by C1 esterase inhibitor deficiency is a rare disorder. Objective To compare the efficacy of pasteurized concentrate (Berinert, CSL Behring) at intravenous doses 10 or 20 U/kg body weight with placebo in treatment single, acute abdominal facial attacks patients hereditary angioedema. Methods This was randomized, double-blind, placebo-controlled study 125 type I II The primary outcome time from start to onset symptom relief. Secondary outcomes were complete resolution, proportion worsened intensity symptoms between 2 and 4hours after treatment, number vomiting episodes within 4 hours. Results Median relief significantly shorter dose than (0.5 vs 1.5 hours; P = .0025), whereas U/kg, only slightly (1.2 .2731). Compared placebo, reduction greatest for severe 13.5 hours). secondary consistently supported dose. safe well tolerated. No seroconversions observed HIV, hepatitis virus, human B19 virus. Conclusion given intravenously an effective angioedema, rapid

参考文章(32)
Bruce L. Zuraw, Hereditary Angioedema New England Journal of Medicine. ,vol. 359, pp. 1027- 1036 ,(2008) , 10.1056/NEJMCP0803977
Andrew Issekutz, Azza Hamed, Palinder Kamra, John Dean, Amin Kanani, Donald Stark, Georges-Etienne Rivard, Eric Leith, Ellie Tsai, Susan Waserman, Paul K. Keith, David Page, Silvia Marchesin, Hilary J. Longhurst, Wolfhart Kreuz, Eva Rusicke, Inmaculada Martinez-Saguer, Emel Aygören-Pürsün, George Harmat, George Füst, Henry Li, Laurence Bouillet, Teresa Caballero, Dumitru Moldovan, Peter J. Späth, Sara Smith-Foltz, Istvan Nagy, Erik W. Nielsen, Christoph Bucher, Patrik Nordenfelt, Zhi Yu Xiang, Tom Bowen, Marco Cicardi, Konrad Bork, Bruce Zuraw, Mike Frank, Bruce Ritchie, Henriette Farkas, Lilian Varga, Lorenza C. Zingale, Karen Binkley, Eric Wagner, Peggy Adomaitis, Kristylea Brosz, Jeanne Burnham, Richard Warrington, Chrystyna Kalicinsky, Sean Mace, Christine McCusker, Robert Schellenberg, Lucia Celeste, Jacques Hebert, Karen Valentine, Man-Chiu Poon, Bazir Serushago, Doris Neurath, William Yang, Gina Lacuesta, Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema Annals of Allergy Asthma & Immunology. ,vol. 100, ,(2008) , 10.1016/S1081-1206(10)60584-4
Konrad Bork, Petra Staubach, Alexander J. Eckardt, Jochen Hardt, Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. The American Journal of Gastroenterology. ,vol. 101, pp. 619- 627 ,(2006) , 10.1111/J.1572-0241.2006.00492.X
A. M. Johnson, C. A. Alper, F. S. Rosen, J. M. Craig, C1 Inhibitor: Evidence for Decreased Hepatic Synthesis in Hereditary Angioneurotic Edema Science. ,vol. 173, pp. 553- 554 ,(1971) , 10.1126/SCIENCE.173.3996.553
Anna Carugati, Emanuela Pappalardo, Lorenz C Zingale, Marco Cicardi, C1-inhibitor deficiency and angioedema. Molecular Immunology. ,vol. 38, pp. 161- 173 ,(2001) , 10.1016/S0161-5890(01)00040-2
Marco Cicardi, Lorenza Chiara Zingale, Andrea Zanichelli, Daniela Lambertenghi Deliliers, Sonia Caccia, The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema. Expert Opinion on Pharmacotherapy. ,vol. 8, pp. 3173- 3181 ,(2007) , 10.1517/14656566.8.18.3173
M. M. Gompels, R. J. Lock, M. Abinun, C. A. Bethune, G. Davies, C. Grattan, A. C. Fay, H. J. Longhurst, L. Morrison, A. Price, M. Price, D. Watters, C1 inhibitor deficiency: consensus document Clinical and Experimental Immunology. ,vol. 139, pp. 379- 394 ,(2005) , 10.1111/J.1365-2249.2005.02726.X